These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36480256)

  • 21. Coverage for Continuous Glucose Monitoring for Individuals with Type 2 Diabetes Treated with Nonintensive Therapies: An Evidence-Based Approach to Policymaking.
    Aleppo G; Hirsch IB; Parkin CG; McGill J; Galindo R; Kruger DF; Levy CJ; Forlenza GP; Umpierrez GE; Grunberger G; Bergenstal RM
    Diabetes Technol Ther; 2023 Oct; 25(10):741-751. PubMed ID: 37471068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparing Continuous Glucose Monitoring and Blood Glucose Monitoring in Adults With Inadequately Controlled, Insulin-Treated Type 2 Diabetes (Steno2tech Study): A 12-Month, Single-Center, Randomized Controlled Trial.
    Lind N; Christensen MB; Hansen DL; Nørgaard K
    Diabetes Care; 2024 May; 47(5):881-889. PubMed ID: 38489032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical efficacy of Professional Continuous Glucose Monitoring in improving glycemic control among children with Type 1 Diabetes Mellitus: An Open-label Randomized Control Trial.
    Raviteja KV; Kumar R; Dayal D; Sachdeva N
    Sci Rep; 2019 Apr; 9(1):6120. PubMed ID: 30992480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continuous glucose monitoring and insulin pump therapy in pregnant women with type 1 diabetes mellitus.
    Lason I; Cyganek K; Witek P; Matejko B; Malecki MT; Skupien J
    Ginekol Pol; 2021; 92(10):675-681. PubMed ID: 33914316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of G5 Mobile continuous glucose monitoring device compared to self-monitoring of blood glucose alone for people with type 1 diabetes from the Canadian societal perspective.
    Chaugule S; Graham C
    J Med Econ; 2017 Nov; 20(11):1128-1135. PubMed ID: 28745578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Efficacy of Two Different Methods to Initiate Sensor-Augmented Insulin Pumps: A Randomized Controlled Trial.
    Moreno-Fernandez J; Gómez FJ; Gálvez Moreno MÁ; Castaño JP
    J Diabetes Res; 2016; 2016():4171789. PubMed ID: 28004007
    [No Abstract]   [Full Text] [Related]  

  • 27. Partnering for Better Health: Using Continuous Glucose Monitoring and Clinical Pharmacist Collaboration to Improve Glycemic Control in Underserved Patients With Type 2 Diabetes.
    Powell J; Mulani SR
    Clin Ther; 2024 Jan; 46(1):e7-e11. PubMed ID: 38165024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continuous Glucose Monitor Use Prevents Glycemic Deterioration in Insulin-Treated Patients with Type 2 Diabetes.
    Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R
    Diabetes Technol Ther; 2022 May; 24(5):332-337. PubMed ID: 35104159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of Continuous Glucose Monitoring on Metrics of Glycemic Control in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Uhl S; Choure A; Rouse B; Loblack A; Reaven P
    J Clin Endocrinol Metab; 2024 Mar; 109(4):1119-1131. PubMed ID: 37987208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Magnitude of Glycemic Improvement in Patients with Type 2 Diabetes Treated with Basal Insulin: Subgroup Analyses from the MOBILE Study.
    Davis G; Bailey R; Calhoun P; Price D; Beck RW
    Diabetes Technol Ther; 2022 May; 24(5):324-331. PubMed ID: 34962151
    [No Abstract]   [Full Text] [Related]  

  • 31. The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin.
    Aleppo G; Beck RW; Bailey R; Ruedy KJ; Calhoun P; Peters AL; Pop-Busui R; Philis-Tsimikas A; Bao S; Umpierrez G; Davis G; Kruger D; Bhargava A; Young L; Buse JB; McGill JB; Martens T; Nguyen QT; Orozco I; Biggs W; Lucas KJ; Polonsky WH; Price D; Bergenstal RM; ;
    Diabetes Care; 2021 Dec; 44(12):2729-2737. PubMed ID: 34588210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of continuous glucose monitoring-guided glycemic control on progression of coronary atherosclerosis in type 2 diabetic patients with coronary artery disease: The OPTIMAL randomized clinical trial.
    Kataoka Y; Kitahara S; Funabashi S; Makino H; Matsubara M; Matsuo M; Omura-Ohata Y; Koezuka R; Tochiya M; Tamanaha T; Tomita T; Honda-Kohmo K; Noguchi M; Maruki M; Kanai E; Murai K; Iwai T; Sawada K; Matama H; Honda S; Fujino M; Yoneda S; Takagi K; Otsuka F; Asaumi Y; Hosoda K; Nicholls SJ; Yasuda S; Noguchi T
    J Diabetes Complications; 2023 Oct; 37(10):108592. PubMed ID: 37741088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Continuous Glucose Monitoring Accuracy on Clinicians' Retrospective Decision Making in Diabetes: A Pilot Study.
    Mahmoudi Z; Johansen MD; Nørgaard HH; Andersen S; Pedersen-Bjergaard U; Tarnow L; Christiansen JS; Hejlesen O
    J Diabetes Sci Technol; 2015 Jun; 9(5):1092-102. PubMed ID: 26055082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Taking a Closer Look--Continuous Glucose Monitoring in Non-Critically Ill Hospitalized Patients with Type 2 Diabetes Mellitus Under Basal-Bolus Insulin Therapy.
    Schaupp L; Donsa K; Neubauer KM; Mader JK; Aberer F; Höll B; Spat S; Augustin T; Beck P; Pieber TR; Plank J
    Diabetes Technol Ther; 2015 Sep; 17(9):611-8. PubMed ID: 25927357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved Effectiveness of Immediate Continuous Glucose Monitoring in Hypoglycemia-Prone People with Type 1 Diabetes Compared with Hypoglycemia-Focused Psychoeducation Following a Previous Structured Education: A Randomized Controlled Trial.
    Serné EH; van den Berg IK; Racca C; van Raalte DH; Kramer MHH; de Wit M; Snoek FJ
    Diabetes Technol Ther; 2023 Jan; 25(1):50-61. PubMed ID: 36326825
    [No Abstract]   [Full Text] [Related]  

  • 36. An exploratory trial of basal and prandial insulin initiation and titration for type 2 diabetes in primary care with adjunct retrospective continuous glucose monitoring: INITIATION study.
    Blackberry ID; Furler JS; Ginnivan LE; Manski-Nankervis JA; Jenkins A; Cohen N; Best JD; Young D; Liew D; Ward G; O'Neal DN
    Diabetes Res Clin Pract; 2014 Nov; 106(2):247-55. PubMed ID: 25271117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuous glucose monitoring for glycaemic control and cardiovascular risk reduction in patients with type 2 diabetes not on insulin therapy: A clinical trial.
    Reed J; Dong T; Eaton E; Friswold J; Porges J; Al-Kindi SG; Rajagopalan S; Neeland IJ
    Diabetes Obes Metab; 2024 Jul; 26(7):2881-2889. PubMed ID: 38680050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Use of Continuous Glucose Monitoring in Adults with Type 1 Diabetes.
    Slattery D; Choudhary P
    Diabetes Technol Ther; 2017 May; 19(S2):S55-S61. PubMed ID: 28541131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
    Beck RW; Riddlesworth T; Ruedy K; Ahmann A; Bergenstal R; Haller S; Kollman C; Kruger D; McGill JB; Polonsky W; Toschi E; Wolpert H; Price D;
    JAMA; 2017 Jan; 317(4):371-378. PubMed ID: 28118453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beneficial effect of real-time continuous glucose monitoring system on glycemic control in type 1 diabetic patients: systematic review and meta-analysis of randomized trials.
    Szypowska A; Ramotowska A; Dzygalo K; Golicki D
    Eur J Endocrinol; 2012 Apr; 166(4):567-74. PubMed ID: 22096111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.